News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Del Carmen Jeffrey
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2023 |
4
| Del Carmen Jeffrey (Chief Commercial Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 3,942 shares
@ $0
Exercised 10,000 restricted stock units
@ $0 |
|
| 12/29/2022 |
4
| Del Carmen Jeffrey (Chief Commercial Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 88,000 options to buy
@ $18.59, valued at
$1.6M
Granted 26,000 restricted stock units
@ $0 |
|
| 11/15/2022 |
4
| Del Carmen Jeffrey (Chief Commercial Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Sold 120,000 shares
@ $16.228, valued at
$1.9M
Sold 19,017 shares
@ $15.461, valued at
$294k
Exercised 120,000 options to buy
@ $2.86, valued at
$343.2k
Exercised 19,017 options to buy
@ $2.24, valued at
$42.6k
|
|
| 08/22/2022 |
4
| Del Carmen Jeffrey (Chief Commercial Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Sold 14,140 shares
@ $14.05, valued at
$198.7k
|
|
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| Del Carmen Jeffrey (Chief Commercial Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 32,000 restricted stock units
@ $0 |
|
| 12/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|